An RNA transmethylation pathway governs kidney nephrogenic potential
- PMID: 40436842
- PMCID: PMC12120073
- DOI: 10.1038/s41467-025-60097-6
An RNA transmethylation pathway governs kidney nephrogenic potential
Abstract
The adult kidney lacks the ability to generate new nephrons, placing individuals born with low nephron counts at greater risk for chronic kidney disease as they age. Limited nutrient availability hinders nephron formation; however, the key metabolic dependencies remain unclear. Here we show that S-adenosylmethionine (SAM) and cellular transmethylation status are crucial determinants of the kidney's nephrogenic capacity. The RNA methyltransferase METTL3 serves as a SAM sensor and is essential for the fate determination of nephron progenitor cells (NPCs). Reducing transmethylation or inhibiting METTL3 blocks NPC differentiation and nephrogenesis, whereas enhancing transmethylation or increasing METTL3 activity facilitates an induced NPC population and increases nephron production. Additionally, we identify Lrpprc mRNA, encoding a mitochondrially enriched protein, as a key direct target of METTL3-mediated transmethylation. Accordingly, inhibiting LRPPRC negates the nephrogenic effects of SAM and METTL3. Our findings reveal a modifiable methionine-SAM-RNA transmethylation pathway that can be targeted to enhance nephron formation.
© 2025. The Author(s).
Conflict of interest statement
Competing interests: V.P. has served as a scientific consultant for Otsuka Pharmaceuticals, Maze Therapeutics, Travere Therapeutics, and Regulus Therapeutics. V.P. serves as the chair of the Scientific Advisory Panel for the PKD Foundation. V.P. lab has a sponsored research agreement with Regulus Therapeutics, which is unrelated to this work. V.P. has licensed patents (US11168325B2) involving anti-miR-17 for the treatment of ADPKD (Inventors: John R. Androsavich, B. Nelson Chau, and Vishal D. Patel. Current Assignee: Regulus Therapeutics Inc. and University of Texas System), which is unrelated to the current manuscript. The remaining authors declare no competing interests.
Figures






References
-
- Puelles, V. G. et al. Glomerular number and size variability and risk for kidney disease. Curr. Opin. Nephrol. Hypertens.20, 7–15 (2011). - PubMed
-
- Hughson, M., Farris, A. B. 3rd, Douglas-Denton, R., Hoy, W. E. & Bertram, J. F. Glomerular number and size in autopsy kidneys: the relationship to birth weight. Kidney Int.63, 2113–2122 (2003). - PubMed
-
- Luyckx, V. A. & Brenner, B. M. The clinical importance of nephron mass. J. Am. Soc. Nephrol.21, 898–910 (2010). - PubMed
MeSH terms
Substances
Grants and funding
- R01DK102572/U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases)
- RC2 DK125960/DK/NIDDK NIH HHS/United States
- R01 DK090127/DK/NIDDK NIH HHS/United States
- R01 DK102572/DK/NIDDK NIH HHS/United States
- R01 DK133186/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Molecular Biology Databases